Anatara : No “Captnludd”, you are the “shitwit”

You see what I have to put up with? It’s not just the hundreds of abusive emails a week, the occasional threatened lawsuits – but its the idiots on HotCopper. EVERY SINGLE WEEK. Relentlessly. I recently posted about Anatara (ASX : ANR). I thought my analysis was fair. I didn’t lambaste the company. I didn’t…

Prima Files a Patent

Prima has had an amazing couple of couple of weeks. A stratospheric stock adjustment that seems to have stuck (nice!). Some good visibility, no doubt, around ASCO time which is great. There remains an odd, slightly contrived echo of jubilation that CVac is an exciting outcome (I’ve already addressed this┬áso I am not going to…

Cynata Therapeutics : The Flip Flop

I make no effort to hide the fact that Cynata (ASX : CYP) is one of the ASX-listed biotechnology companies that I despise the most. It is the worst example of a “hollow chocolate bunny” that will only ever deliver on wild speculation from retail punters wowed by the words “stem cells.” If, one day,…

No Bacon in BLT

What do you think of my bacon gene silencing gag, pretty cool eh? I do love the sizzle of bacon… Firstly, I would like to start this blog post by apologising to Benitec, and particularly Peter French (CEO). In my last entry, I broke one of my own purported rules and that was not to…

Nothing “Novo” about Novogen

I’ll keep this brief, because there isn’t much to say. My ire with this company blossomed last month when it announced that it had filed a patent. Yes, you heard me correctly. They didn’t receive a notice of allowance on a patent. They didn’t expand their intellectual property (IP) into an international territory of commercial…